Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease

被引:41
作者
Visser, Pieter Jelle [1 ,2 ]
Vos, Stephanie [1 ]
van Rossum, Ineke [2 ]
Scheltens, Philip [2 ]
机构
[1] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Alzheimer Ctr, Amsterdam, Netherlands
关键词
Alzheimer's disease; Diagnosis; Biomarkers; Neuropsychology; MCI; MILD COGNITIVE IMPAIRMENT; CSF BIOMARKERS PREDICT; DIAGNOSTIC GUIDELINES; RECOMMENDATIONS; PROGRESSION; WORKGROUPS; DEMENTIA; MARKERS;
D O I
10.1016/j.jalz.2011.10.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Two sets of research criteria for Alzheimer's disease are now available: those published by an International Working Group in 2007, and the recommendations published by the National Institute on Aging and the Alzheimer's Association (NIA-AA) in 2011. They both provide guidelines for the diagnosis of asymptomatic and symptomatic Alzheimer's disease. The coexistence of two sets of criteria for the same disorder raises the question of which set of criteria should be preferred. A comparison of the criteria revealed differences in approach, terminology, and use of cognitive markers and biomarkers. Most persons who meet the International Working Group criteria will also meet the NIA-AA criteria and vice versa. However, the NIA-AA criteria allow for a subclassification of persons based on biomarker results within each diagnostic category. Further research is needed to validate the criteria. Modifications are likely to be made before the criteria can be used in daily practice. (C) 2012 The Alzheimer's Association. All rights reserved.
引用
收藏
页码:560 / 563
页数:4
相关论文
共 18 条
[1]   The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[2]   Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria [J].
Dubois, Bruno ;
Feldman, Howard H. ;
Jacova, Claudia ;
Dekosky, Steven T. ;
Barberger-Gateau, Pascale ;
Cummings, Jeffrey ;
Delocourte, Andre ;
Galasko, Douglas ;
Gauthier, Serge ;
Jicha, Gregory ;
Meguro, Kenichi ;
O'Brien, John ;
Pasquier, Florence ;
Robert, Philippe ;
Rossor, Martin ;
Solloway, Steven ;
Stern, Yaakov ;
Visser, Pieter J. ;
Scheltens, Philip .
LANCET NEUROLOGY, 2007, 6 (08) :734-746
[3]   Revising the definition of Alzheimer's disease: a new lexicon [J].
Dubois, Bruno ;
Feldman, Howard H. ;
Jacova, Claudia ;
Cummings, Jeffrey L. ;
DeKosky, Steven T. ;
Barberger-Gateau, Pascale ;
Delacourte, Andre ;
Frisoni, Giovanni ;
Fox, Nick C. ;
Galasko, Douglas ;
Gauthier, Serge ;
Hampel, Harald ;
Jicha, Gregory A. ;
Meguro, Kenichi ;
O'Brien, John ;
Pasquier, Florence ;
Robert, Philippe ;
Rossor, Martin ;
Salloway, Steven ;
Sarazin, Marie ;
de Souza, Leonardo C. ;
Stern, Yaakov ;
Visser, Pieter J. ;
Scheltens, Philip .
LANCET NEUROLOGY, 2010, 9 (11) :1118-1127
[4]   In vivo amyloid imaging with PET in frontotemporal dementia [J].
Engler, Henry ;
Santillo, Alexander Frizell ;
Wang, Shu Xia ;
Lindau, Maria ;
Savitcheva, Irina ;
Nordberg, Agneta ;
Lannfelt, Lars ;
Langstrom, Bengt ;
Kilander, Lena .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (01) :100-106
[5]   Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease [J].
Hansson, Oskar ;
Buchhave, Peder ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Minthon, Lennart ;
Warkentin, Sieabert .
NEUROBIOLOGY OF AGING, 2009, 30 (02) :165-173
[6]   Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease [J].
Jack, Clifford R., Jr. ;
Wiste, Heather J. ;
Vemuri, Prashanthi ;
Weigand, Stephen D. ;
Senjem, Matthew L. ;
Zeng, Guang ;
Bernstein, Matt A. ;
Gunter, Jeffrey L. ;
Pankratz, Vernon S. ;
Aisen, Paul S. ;
Weiner, Michael W. ;
Petersen, Ronald C. ;
Shaw, Leslie M. ;
Trojanowski, John Q. ;
Knopman, David S. .
BRAIN, 2010, 133 :3336-3348
[7]   Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade [J].
Jack, Clifford R., Jr. ;
Knopman, David S. ;
Jagust, William J. ;
Shaw, Leslie M. ;
Aisen, Paul S. ;
Weiner, Michael W. ;
Petersen, Ronald C. ;
Trojanowski, John Q. .
LANCET NEUROLOGY, 2010, 9 (01) :119-128
[8]   CSF biomarkers predict rate of cognitive decline in Alzheimer disease [J].
Kester, M. I. ;
van der Vlies, A. E. ;
Blankenstein, M. A. ;
Pijnenburg, Y. A. L. ;
van Elk, E. J. ;
Scheltens, P. ;
van der Flier, W. M. .
NEUROLOGY, 2009, 73 (17) :1353-1358
[9]   The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
McKhann, Guy M. ;
Knopman, David S. ;
Chertkow, Howard ;
Hyman, Bradley T. ;
Jack, Clifford R., Jr. ;
Kawas, Claudia H. ;
Klunk, William E. ;
Koroshetz, Walter J. ;
Manly, Jennifer J. ;
Mayeux, Richard ;
Mohs, Richard C. ;
Morris, John C. ;
Rossor, Martin N. ;
Scheltens, Philip ;
Carrillo, Maria C. ;
Thies, Bill ;
Weintraub, Sandra ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :263-269
[10]   Mild cognitive impairment as a diagnostic entity [J].
Petersen, RC .
JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) :183-194